Danisco’s phytase dose for swine gets FDA approval
DuPont subsidiary Danisco Animal Nutrition has received approval from the US’s Food and Drug Association (FDA) for their phytase product Axtra PHY dose level for swine (250 FTU/kg feed).
The product offers cost-effective dosing through use of a strong set of matrix values, which are, in turn, supported by numerous worldwide trials at different production stages (weaner and grower/finisher). It is also more bio-efficacious than E.coliphytases, offering:
- Additional cost savings of ~$1.08 per metric tonne (~$0.98 per short ton) of pig feed through its ability to make available ~20% more phosphorus (P) and calcium (Ca) earlier in the digestive process.
- Availability of ~10% more digestible energy to the pig through superior phytate degradation in the upper gut.
- Additional manure management cost savings.
It is available in liquid and dry product forms. If a dry product form is preferred, maximum performance and ease of use is ensured through its Thermo Protection Technology (TPT) granule, ensuring heat stability up to 203°F (95°C). Axtra PHY benefits from strong support services, such as a FASTKit assay which detects the presence of active Axtra PHY in feed and a new online service, Optimize Feed, which helps producers optimise diet formulations to ensure maximum cost savings.
Join 18,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the pigsector, three times a week.
